Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Brouwer

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
International Journal of Cardiology. Heart & Vasculature|August 14, 2023
Efficacy and safety of the endothelin-1 receptor antagonist macitentan in epicardial and microvascular vasospasm; a proof-of-concept studyRutger G T Feenstra, Tijn P J Jansen, S Matthijs Boekholdt, et al.
Blood Cancer Journal|March 10, 2022
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, et al.
Annals of the Rheumatic Diseases|September 16, 2011
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept studyM J H Boumans, J G A Houbiers, P Verschueren, et al.
Emerging Infectious Diseases|June 20, 2012
Retrospective evaluation of control measures for contacts of patient with Marburg hemorrhagic feverAura Timen, Leslie D Isken, Patricia Willemse, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal MeningitisTihana Bicanic, Christian Bottomley, Angela Loyse, et al.
The Lancet. HIV|January 8, 2025
Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohortVita W Jongen, Ferdinand W N M Wit, Anders Boyd, et al.
Plos Pathogens|April 19, 2021
Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotypeOrion Tong, Gabriel Duette, Thomas R O'Neil, et al.
Arthritis and Rheumatism|August 29, 2013
Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohortsA Krabben, A G Wilson, D P C de Rooy, et al.
Lupus|April 20, 2012
Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritisH A Martens, H L A Nienhuis, S Gross, et al.
Blood Cancer Journal|September 2, 2022
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphomaDiana Al-Sarayfi, Frederik O Meeuwes, Müjde Durmaz, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
International Journal of Cardiology. Heart & Vasculature|August 14, 2023
Efficacy and safety of the endothelin-1 receptor antagonist macitentan in epicardial and microvascular vasospasm; a proof-of-concept studyRutger G T Feenstra, Tijn P J Jansen, S Matthijs Boekholdt, et al.
Blood Cancer Journal|March 10, 2022
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, et al.
Annals of the Rheumatic Diseases|September 16, 2011
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept studyM J H Boumans, J G A Houbiers, P Verschueren, et al.
Emerging Infectious Diseases|June 20, 2012
Retrospective evaluation of control measures for contacts of patient with Marburg hemorrhagic feverAura Timen, Leslie D Isken, Patricia Willemse, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal MeningitisTihana Bicanic, Christian Bottomley, Angela Loyse, et al.
The Lancet. HIV|January 8, 2025
Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohortVita W Jongen, Ferdinand W N M Wit, Anders Boyd, et al.
Plos Pathogens|April 19, 2021
Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotypeOrion Tong, Gabriel Duette, Thomas R O'Neil, et al.
Arthritis and Rheumatism|August 29, 2013
Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohortsA Krabben, A G Wilson, D P C de Rooy, et al.
Lupus|April 20, 2012
Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritisH A Martens, H L A Nienhuis, S Gross, et al.
Blood Cancer Journal|September 2, 2022
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphomaDiana Al-Sarayfi, Frederik O Meeuwes, Müjde Durmaz, et al.
Pageof 20